X
19
Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is GLATIRAMER ACETATE, with a corresponding application number 206921.
Regulatory Information RX
With a dosage strength 40MG/ML
Dosage Form Route INJECTABLE; SUBCUTANEOUS
Reference Listed Drug No
Approved since 2018-02-12
Therapeutic Equivalence (TE) Code AP